Advertisement

ABD Eyes Mohs Certification, Sun's Ilumya Approved, FUE Update
ABD Eyes Mohs Certification, Sun's Ilumya Approved, FUE Update

ABD Eyes Mohs Certification, Sun's Ilumya Approved, FUE Update

The American Board of Dermatology has notified the American Board of Medical Specialties it wants to offer a subspecialty certificate in Micrographic Dermatologic Surgery. Dermatologists react. Ilumya or tildrakizumab from Sun Pharma is approved for moderate to severe psoriasis. Medicine the Musical could be coming to off-broadway this fall. And there's a dermatologist to thank for it. The International Society of Hair Restoration Surgery has updated the terminology of the hair transplantation method known as FUE from Follicular Unit Extraction to Follicular Unit Excision. EDITOR'S NOTE: The initial broadcast incorrectly reported 28-week placebo data for Ilumya. Placebo data were only reported for Week 64.

Advertisement